{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:14:29Z","timestamp":1779196469172,"version":"3.51.4"},"reference-count":10,"publisher":"BMJ","issue":"4","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 GM115516"],"award-info":[{"award-number":["U54 GM115516"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015160","name":"Hologic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2025,11,13]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The Centers for Disease Control guidelines recommend rescreening for chlamydia, gonorrhoea and trichomoniasis 3\u2009months after treatment to detect reinfection. This intervention aimed to improve rescreening rates by removing multiple logistical and financial barriers to rescreening within our influence for the greatest possible effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>For 1 year (2022, n=837), free (to the patient) rescreen tests were automatically mailed to all patients in 21 health centres 3\u2009months after they were treated for chlamydia, gonorrhoea and\/or trichomoniasis, unless they opted out or were rescreened sooner. Patients returned the completed mail-in self-collection kit in a prepaid envelope within 2\u20134 weeks. Rescreening rates were compared with a control period (2019, n=1743).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2580 rescreen opportunities (intervention=837, control=1743) were tracked for rescreening. The median age was 23, 66% were female, 80% were white and 79% tested positive for chlamydia. The intervention increased rescreening rates from 22% to 26%, which was not statistically significant after adjustment (OR 1.20, 95%\u2009CI 0.98 to 1.48, p=0.08).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A 4% increase in rescreening rates did not justify programme continuation. While rescreening has been an important public health strategy to reduce sexually transmitted infections (STIs), this programme reveals that high rates of rescreening may not be possible. Recommending rescreening and making it free, convenient and automatic is not enough. Without new ideas and approaches to tackling this public health problem, STI reinfection and resulting reproductive health complications will persist.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/sextrans-2025-056648","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:13:50Z","timestamp":1765278830000},"page":"258-260","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a free mail-in opt-out STI testing programme on 3-month rescreening rates in reproductive health centres"],"prefix":"10.1136","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6364-8266","authenticated-orcid":false,"given":"Stephanie L","family":"Small","sequence":"first","affiliation":[{"name":"Planned Parenthood of Northern New England, Topsham, Maine, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-3570","authenticated-orcid":false,"given":"Jonathan F","family":"Emery","sequence":"additional","affiliation":[{"name":"University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicki","family":"Hart","sequence":"additional","affiliation":[{"name":"DLH Corporation, Silver Spring, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9213-4638","authenticated-orcid":false,"given":"Olivia A","family":"Tarmey","sequence":"additional","affiliation":[{"name":"University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzerie","family":"de Jager","sequence":"additional","affiliation":[{"name":"University of Vermont, Burlington, Vermont, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"2026051905450667000_102.4.258.1","doi-asserted-by":"publisher","DOI":"10.1097\/olq.0000000000001355"},{"key":"2026051905450667000_102.4.258.2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41564-022-01177-x","article-title":"Sexually transmitted infections and female reproductive health","volume":"7","author":"Van Gerwen","year":"2022","journal-title":"Nat Microbiol"},{"key":"2026051905450667000_102.4.258.3","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181a2a933"},{"key":"2026051905450667000_102.4.258.4","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2006.024059"},{"key":"2026051905450667000_102.4.258.5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7005a1"},{"key":"2026051905450667000_102.4.258.6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jadohealth.2022.06.014","article-title":"Chlamydia Trachomatis\/Neisseria Gonorrhea Retesting Among Adolescents and Young Adults in a Primary Care Network","volume":"71","author":"Teixeira da Silva","year":"2022","journal-title":"J Adolesc Health"},{"key":"2026051905450667000_102.4.258.7","doi-asserted-by":"crossref","first-page":"1031372","DOI":"10.3389\/fpubh.2022.1031372","article-title":"Determinants and prediction of Chlamydia trachomatis re-testing and re-infection within 1 year among heterosexuals with chlamydia attending a sexual health clinic","volume":"10","author":"Xu","year":"2023","journal-title":"Front Public Health"},{"key":"2026051905450667000_102.4.258.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amepre.2015.01.014","article-title":"Dual Intervention to Increase Chlamydia Retesting: A Randomized Controlled Trial in Three Populations","volume":"49","author":"Smith","year":"2015","journal-title":"Am J Prev Med"},{"key":"2026051905450667000_102.4.258.9","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/OLQ.0000000000000294","article-title":"Interventions to Improve Sexually Transmitted Disease Screening in Clinic-Based Settings","volume":"43","author":"Taylor","year":"2016","journal-title":"Sex Transm Dis"},{"key":"2026051905450667000_102.4.258.10","unstructured":"FY23 annual exam. Available: www.plannedparenthood.org\/planned-parenthood-northern-new-england\/about-us\/publications [Accessed 15 Sep 2025]."}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2025-056648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:45:32Z","timestamp":1779194732000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2025-056648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":10,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,5,19]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/sextrans-2025-056648"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2025-056648","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}